Market Insights Health Medical Technology Medical Devices

Endoscopic Devices - G20

The Endoscopic Devices market market in G20 is expected to see significant growth in the coming years.
According to projections, the revenue in this market is set to reach an impressive US$24.77bn by 2024.
This indicates a promising future for the industry.
Furthermore, it is estimated that the market will continue to expand at a compound annual growth rate (CAGR) of 6.99% between 2024 and 2029.
This steady growth is forecasted to result in a market volume of approximately US$34.73bn by 2029.
In terms of global comparison, it is worth noting that the United States is expected to generate the highest revenue in the Endoscopic Devices market market within the in G20 countries.
Projections indicate that the US market will reach a revenue of US$10,390.00m by 2024.
This highlights the significant contribution of the United States to the overall market.
In the G20 country of Germany, there is a growing trend in the Endoscopic Devices market towards advanced imaging technologies and minimally invasive procedures.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.